Blood Gas And Electrolyte Analyzer Market Size, Share & Trends Analysis Report By Products (Instruments, Consumables), By End-use (Clinical Laboratory, Point-of-care), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
Blood Gas And Electrolyte Analyzer Market Growth & Trends
The global blood gas and electrolyte analyzer market size is expected t%li%reach USD 3.71 billion by 2030, registering a CAGR of 4.5%, according t%li%a new study by Grand View Research Inc. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely t%li%drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is als%li%expected t%li%significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care. Furthermore, the emergence of multi-parameter monitoring devices owing to, expanding test menus and growing demand for portable devices is expected t%li%boost usage rates over the forecast period. The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability t%li%guide prognosis and therapy. Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.
Blood Gas And Electrolyte Analyzer Market Report Highlights
Blood Gas And Electrolyte Analyzer Market Growth & Trends
The global blood gas and electrolyte analyzer market size is expected t%li%reach USD 3.71 billion by 2030, registering a CAGR of 4.5%, according t%li%a new study by Grand View Research Inc. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely t%li%drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is als%li%expected t%li%significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care. Furthermore, the emergence of multi-parameter monitoring devices owing to, expanding test menus and growing demand for portable devices is expected t%li%boost usage rates over the forecast period. The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability t%li%guide prognosis and therapy. Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.
Blood Gas And Electrolyte Analyzer Market Report Highlights
- Consumables dominated the market with a revenue share of 66.28% in 2023 and is anticipated t%li%grow at the fastest growth rate over the forecast period, driven by their increasing demand.
- Clinical laboratory dominated the market with a revenue market share of 46.98% in 2023. In the rapidly advancing landscape of healthcare technology, Blood Gas Analyzers (BGAs) have become indispensable for clinical laboratories, offering real-time insights int%li%a patient's respiratory and metabolic status.
- North America accounted for 42.22% of the blood gas and electrolyte analyzers market in 2023. Presence of sophisticated healthcare infrastructure along with favorable reimbursement plans are some key factors expected t%li%drive regional market growth.
- Presence of high unmet needs clubbed with rapidly improving healthcare infrastructure in the emerging markets of India and China is expected t%li%help Asia Pacific grow at a lucrative rate throughout the forecast period. Growing demand for decentralized point-of-care diagnostic facilities handling large volumes of diagnostic tests is als%li%expected t%li%drive regional market growth.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product and end-use outlook
2.2.2. Regional outlook
2.3. Competitive Insights
CHAPTER 3. BLOOD GAS AND ELECTROLYTE ANALYZER MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing prevalence of chronic diseases
3.2.1.2. Rising geriatric population
3.2.1.3. Increasing regulatory support and funding
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of advanced analyzers
3.2.2.2. Shortage of skilled professionals
3.3. Blood Gas and Electrolyte Analyzer Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. BLOOD GAS AND ELECTROLYTE ANALYZER MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Global Blood Gas and Electrolyte Analyzer Market: Product Dashboard
4.2. Global Blood Gas and Electrolyte Analyzer Market: Product Movement Analysis
4.3. Global Blood Gas and Electrolyte Analyzer Market by Product, Revenue
4.4. Instruments
4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2. Instruments, by Type
4.4.3. Bench Top
4.4.3.1. Benchtop instruments market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4. Portable
4.4.4.1. Portable instruments market estimates and forecasts 2018 - 2030 (USD Million)
4.4.5. Instruments, by Brand
4.4.6. I-STAT
4.4.6.1. I-STAT market estimates and forecasts 2018 - 2030 (USD Million)
4.4.7. epoc
4.4.7.1. epoc market estimates and forecasts 2018 - 2030 (USD Million)
4.4.8. GEM Premier (3500& 5000)
4.4.8.1. GEM Premier (3500& 5000) market estimates and forecasts 2018 - 2030 (USD Million)
4.4.9. ABL Flex (90 and 800)
4.4.9.1. ABL Flex (90 and 800) market estimates and forecasts 2018 - 2030 (USD Million)
4.4.10. Cobas
4.4.10.1. Cobas market estimates and forecasts 2018 - 2030 (USD Million)
4.4.11. Portable RAPID Series
4.4.11.1. RAPID series market estimates and forecasts 2018 - 2030 (USD Million)
4.4.12. Others
4.4.12.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Consumables
4.5.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. BLOOD GAS AND ELECTROLYTE ANALYZER MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Global Blood Gas and Electrolyte Analyzer Market: End Use Dashboard
5.2. Global Blood Gas and Electrolyte Analyzer Market: End Use Movement Analysis
5.3. Global Blood Gas and Electrolyte Analyzer Market by End Use, Revenue
5.4. Clinical Laboratory
5.4.1. Clinical laboratory market estimates and forecasts 2018 - 2030 (USD Million)
5.5. Point-of-care
5.5.1. Point-of-care market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Diagnostic Centers
5.6.1. Diagnostic centers market estimates and forecasts 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. BLOOD GAS AND ELECTROLYTE ANALYZER MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT AND END USE
6.1. Regional Dashboard
6.2. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
6.3. North America
6.3.1. U.S.
6.3.1.1. Key country dynamics
6.3.1.2. Regulatory framework/ reimbursement structure
6.3.1.3. Competitive scenario
6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
6.3.2. Canada
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
6.4.2. Germany
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
6.4.3. France
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
6.4.4. Italy
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
6.4.5. Spain
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
6.4.6. Norway
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
6.5.3. India
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
6.5.4. Australia
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
6.5.6. Singapore
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
6.5.7. Malaysia
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. China market estimates and forecasts 2018 - 2030 (USD Million)
6.5.8. Indonesia
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. India market estimates and forecasts 2018 - 2030 (USD Million)
6.5.9. Thailand
6.5.9.1. Key country dynamics
6.5.9.2. Regulatory framework/ reimbursement structure
6.5.9.3. Competitive scenario
6.5.9.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
6.5.10. Vietnam
6.5.10.1. Key country dynamics
6.5.10.2. Regulatory framework/ reimbursement structure
6.5.10.3. Competitive scenario
6.5.10.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
6.5.11. Philippines
6.5.11.1. Key country dynamics
6.5.11.2. Regulatory framework/ reimbursement structure
6.5.11.3. Competitive scenario
6.5.11.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
6.6.2. Mexico
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
6.7.3. UAE
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
6.7.4. Kuwait
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Abbott
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Meizhou Cornley High-Tech Co., Ltd.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Radiometer Medical ApS
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. EDAN Instruments, Inc.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Erba Mannheim
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. F. Hoffmann-La Roche Ltd
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Fortress Diagnostics
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Werfen
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. LifeHealth
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Medica Corporation
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. OPTI Medical Systems, Inc.,
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
7.3.15. Sensa Core
7.3.15.1. Company overview
7.3.15.2. Financial performance
7.3.15.3. Product benchmarking
7.3.15.4. Strategic initiatives
7.3.16. Siemens Healthineers AG
7.3.16.1. Company overview
7.3.16.2. Financial performance
7.3.16.3. Product benchmarking
7.3.16.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product and end-use outlook
2.2.2. Regional outlook
2.3. Competitive Insights
CHAPTER 3. BLOOD GAS AND ELECTROLYTE ANALYZER MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing prevalence of chronic diseases
3.2.1.2. Rising geriatric population
3.2.1.3. Increasing regulatory support and funding
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of advanced analyzers
3.2.2.2. Shortage of skilled professionals
3.3. Blood Gas and Electrolyte Analyzer Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. BLOOD GAS AND ELECTROLYTE ANALYZER MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Global Blood Gas and Electrolyte Analyzer Market: Product Dashboard
4.2. Global Blood Gas and Electrolyte Analyzer Market: Product Movement Analysis
4.3. Global Blood Gas and Electrolyte Analyzer Market by Product, Revenue
4.4. Instruments
4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2. Instruments, by Type
4.4.3. Bench Top
4.4.3.1. Benchtop instruments market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4. Portable
4.4.4.1. Portable instruments market estimates and forecasts 2018 - 2030 (USD Million)
4.4.5. Instruments, by Brand
4.4.6. I-STAT
4.4.6.1. I-STAT market estimates and forecasts 2018 - 2030 (USD Million)
4.4.7. epoc
4.4.7.1. epoc market estimates and forecasts 2018 - 2030 (USD Million)
4.4.8. GEM Premier (3500& 5000)
4.4.8.1. GEM Premier (3500& 5000) market estimates and forecasts 2018 - 2030 (USD Million)
4.4.9. ABL Flex (90 and 800)
4.4.9.1. ABL Flex (90 and 800) market estimates and forecasts 2018 - 2030 (USD Million)
4.4.10. Cobas
4.4.10.1. Cobas market estimates and forecasts 2018 - 2030 (USD Million)
4.4.11. Portable RAPID Series
4.4.11.1. RAPID series market estimates and forecasts 2018 - 2030 (USD Million)
4.4.12. Others
4.4.12.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Consumables
4.5.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. BLOOD GAS AND ELECTROLYTE ANALYZER MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Global Blood Gas and Electrolyte Analyzer Market: End Use Dashboard
5.2. Global Blood Gas and Electrolyte Analyzer Market: End Use Movement Analysis
5.3. Global Blood Gas and Electrolyte Analyzer Market by End Use, Revenue
5.4. Clinical Laboratory
5.4.1. Clinical laboratory market estimates and forecasts 2018 - 2030 (USD Million)
5.5. Point-of-care
5.5.1. Point-of-care market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Diagnostic Centers
5.6.1. Diagnostic centers market estimates and forecasts 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. BLOOD GAS AND ELECTROLYTE ANALYZER MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT AND END USE
6.1. Regional Dashboard
6.2. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
6.3. North America
6.3.1. U.S.
6.3.1.1. Key country dynamics
6.3.1.2. Regulatory framework/ reimbursement structure
6.3.1.3. Competitive scenario
6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
6.3.2. Canada
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
6.4.2. Germany
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
6.4.3. France
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
6.4.4. Italy
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
6.4.5. Spain
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
6.4.6. Norway
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
6.5.3. India
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
6.5.4. Australia
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
6.5.6. Singapore
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
6.5.7. Malaysia
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. China market estimates and forecasts 2018 - 2030 (USD Million)
6.5.8. Indonesia
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. India market estimates and forecasts 2018 - 2030 (USD Million)
6.5.9. Thailand
6.5.9.1. Key country dynamics
6.5.9.2. Regulatory framework/ reimbursement structure
6.5.9.3. Competitive scenario
6.5.9.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
6.5.10. Vietnam
6.5.10.1. Key country dynamics
6.5.10.2. Regulatory framework/ reimbursement structure
6.5.10.3. Competitive scenario
6.5.10.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
6.5.11. Philippines
6.5.11.1. Key country dynamics
6.5.11.2. Regulatory framework/ reimbursement structure
6.5.11.3. Competitive scenario
6.5.11.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
6.6.2. Mexico
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
6.7.3. UAE
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
6.7.4. Kuwait
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Abbott
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Meizhou Cornley High-Tech Co., Ltd.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Radiometer Medical ApS
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. EDAN Instruments, Inc.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Erba Mannheim
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. F. Hoffmann-La Roche Ltd
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Fortress Diagnostics
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Werfen
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. LifeHealth
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Medica Corporation
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. OPTI Medical Systems, Inc.,
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
7.3.15. Sensa Core
7.3.15.1. Company overview
7.3.15.2. Financial performance
7.3.15.3. Product benchmarking
7.3.15.4. Strategic initiatives
7.3.16. Siemens Healthineers AG
7.3.16.1. Company overview
7.3.16.2. Financial performance
7.3.16.3. Product benchmarking
7.3.16.4. Strategic initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 4 Global Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 5 Global Blood Gas and Electrolyte Analyzer, by Region, 2018 - 2030 (USD Million)
Table 6 North America Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
Table 7 North America Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 8 North America Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 9 U.S. Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 10 U.S. Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 11 Canada Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 12 Canada Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 13 Europe Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
Table 14 Europe Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 15 Europe Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 16 Germany Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 17 Germany Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 18 UK Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 19 UK Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 20 France Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 21 France Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 22 Italy Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 23 Italy Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 24 Spain Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 25 Spain Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 26 Denmark Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 27 Denmark Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 28 Sweden Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 29 Sweden Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 30 Norway Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 31 Norway Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 32 Asia Pacific Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
Table 33 Asia Pacific Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 35 China Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 36 China Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 37 Japan Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 38 Japan Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 39 India Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 40 India Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 41 South Korea Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 42 South Korea Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 43 Australia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 44 Australia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 45 Singapore Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 46 Singapore Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 47 Malaysia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 48 Malaysia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 49 Indonesia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 50 Indonesia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 51 Thailand Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 52 Thailand Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 53 Vietnam Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 54 Vietnam Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 55 Philippines Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 56 Philippines Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 57 Latin America Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
Table 58 Latin America Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 59 Latin America Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 60 Brazil Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 61 Brazil Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 62 Mexico Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 63 Mexico Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 64 Argentina Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 65 Argentina Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 66 Middle East & Africa Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
Table 67 Middle East & Africa Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 68 Middle East & Africa Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 69 South Africa Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 70 South Africa Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 71 Saudi Arabia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 72 Saudi Arabia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 73 UAE Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 74 UAE Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 75 Kuwait Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 76 Kuwait Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 4 Global Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 5 Global Blood Gas and Electrolyte Analyzer, by Region, 2018 - 2030 (USD Million)
Table 6 North America Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
Table 7 North America Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 8 North America Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 9 U.S. Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 10 U.S. Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 11 Canada Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 12 Canada Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 13 Europe Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
Table 14 Europe Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 15 Europe Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 16 Germany Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 17 Germany Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 18 UK Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 19 UK Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 20 France Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 21 France Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 22 Italy Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 23 Italy Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 24 Spain Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 25 Spain Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 26 Denmark Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 27 Denmark Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 28 Sweden Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 29 Sweden Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 30 Norway Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 31 Norway Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 32 Asia Pacific Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
Table 33 Asia Pacific Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 35 China Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 36 China Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 37 Japan Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 38 Japan Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 39 India Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 40 India Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 41 South Korea Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 42 South Korea Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 43 Australia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 44 Australia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 45 Singapore Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 46 Singapore Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 47 Malaysia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 48 Malaysia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 49 Indonesia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 50 Indonesia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 51 Thailand Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 52 Thailand Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 53 Vietnam Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 54 Vietnam Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 55 Philippines Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 56 Philippines Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 57 Latin America Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
Table 58 Latin America Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 59 Latin America Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 60 Brazil Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 61 Brazil Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 62 Mexico Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 63 Mexico Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 64 Argentina Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 65 Argentina Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 66 Middle East & Africa Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
Table 67 Middle East & Africa Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 68 Middle East & Africa Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 69 South Africa Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 70 South Africa Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 71 Saudi Arabia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 72 Saudi Arabia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 73 UAE Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 74 UAE Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
Table 75 Kuwait Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
Table 76 Kuwait Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Shingles vaccine market: market outlook
Fig. 14 Shingles vaccine market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Shingles vaccine market driver impact
Fig. 18 Shingles vaccine market restraint impact
Fig. 19 Shingles vaccine market: Product movement analysis
Fig. 20 Shingles vaccine market: Product outlook and key takeaways
Fig. 21 Shingrix market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Zostavax market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 SKYZoster market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Shingles vaccine market: Vaccine type movement analysis
Fig. 25 Shingles vaccine market: Vaccine type outlook and key takeaways
Fig. 26 Recombinant Vaccine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Live Attenuated Vaccine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Shingles vaccine market: End Use movement analysis
Fig. 29 Shingles vaccine market: End Use outlook and key takeaways
Fig. 30 Private Healthcare Settings market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Government Healthcare Settings market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Global Shingles vaccine market: Regional movement analysis
Fig. 33 Global Shingles vaccine market: Regional outlook and key takeaways
Fig. 34 Global Shingles vaccine market share and leading players
Fig. 35 North America, by country
Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 U.S. key country dynamics
Fig. 38 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Canada key country dynamics
Fig. 40 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Mexico key country dynamics
Fig. 42 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 UK key country dynamics
Fig. 45 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Germany key country dynamics
Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 France key country dynamics
Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Italy key country dynamics
Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Spain key country dynamics
Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Denmark key country dynamics
Fig. 55 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Sweden key country dynamics
Fig. 57 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Norway key country dynamics
Fig. 59 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 China key country dynamics
Fig. 62 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Japan key country dynamics
Fig. 64 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 India key country dynamics
Fig. 66 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Thailand key country dynamics
Fig. 68 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 South Korea key country dynamics
Fig. 70 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Australia key country dynamics
Fig. 72 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Brazil key country dynamics
Fig. 75 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Argentina key country dynamics
Fig. 77 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 South Africa key country dynamics
Fig. 80 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Saudi Arabia key country dynamics
Fig. 82 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 UAE key country dynamics
Fig. 84 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Kuwait key country dynamics
Fig. 86 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Market share of key market players- Shingles vaccine market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Shingles vaccine market: market outlook
Fig. 14 Shingles vaccine market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Shingles vaccine market driver impact
Fig. 18 Shingles vaccine market restraint impact
Fig. 19 Shingles vaccine market: Product movement analysis
Fig. 20 Shingles vaccine market: Product outlook and key takeaways
Fig. 21 Shingrix market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Zostavax market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 SKYZoster market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Shingles vaccine market: Vaccine type movement analysis
Fig. 25 Shingles vaccine market: Vaccine type outlook and key takeaways
Fig. 26 Recombinant Vaccine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Live Attenuated Vaccine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Shingles vaccine market: End Use movement analysis
Fig. 29 Shingles vaccine market: End Use outlook and key takeaways
Fig. 30 Private Healthcare Settings market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Government Healthcare Settings market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Global Shingles vaccine market: Regional movement analysis
Fig. 33 Global Shingles vaccine market: Regional outlook and key takeaways
Fig. 34 Global Shingles vaccine market share and leading players
Fig. 35 North America, by country
Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 U.S. key country dynamics
Fig. 38 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Canada key country dynamics
Fig. 40 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Mexico key country dynamics
Fig. 42 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 UK key country dynamics
Fig. 45 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Germany key country dynamics
Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 France key country dynamics
Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Italy key country dynamics
Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Spain key country dynamics
Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Denmark key country dynamics
Fig. 55 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Sweden key country dynamics
Fig. 57 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Norway key country dynamics
Fig. 59 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 China key country dynamics
Fig. 62 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Japan key country dynamics
Fig. 64 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 India key country dynamics
Fig. 66 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Thailand key country dynamics
Fig. 68 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 South Korea key country dynamics
Fig. 70 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Australia key country dynamics
Fig. 72 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Brazil key country dynamics
Fig. 75 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Argentina key country dynamics
Fig. 77 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 South Africa key country dynamics
Fig. 80 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Saudi Arabia key country dynamics
Fig. 82 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 UAE key country dynamics
Fig. 84 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Kuwait key country dynamics
Fig. 86 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Market share of key market players- Shingles vaccine market
